Stock Chart
HAE
Type: SELL growth_1yr
Strike: $65
Premium: $4.70
Expiry: Jan 15, 2027
Target: $55
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About HAE - Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for …
Key Statistics
More HAE Analysis
This HAE stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track HAE's price movements with trendlines, gamma walls, and key support/resistance levels.